| 0143-9151 | DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0143-9151-10 | DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0143-9273 | DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0143-9273-01 | DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0143-9273-10 | DIHYDROERGOTAMINE MESYLATE INJECTION, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 24201-463 | Dihydroergotamine Mesylate Nasal Spray The solution used in Dihydroergotamine Mesylate Nasal Spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only | Hikma Pharmaceuticals USA Inc. | MIPHARM SPA |
| 24201-463-08 | Dihydroergotamine Mesylate Nasal Spray The solution used in Dihydroergotamine Mesylate Nasal Spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only | Hikma Pharmaceuticals USA Inc. | MIPHARM SPA |
| 36000-300 | Dihydroergotamine Mesylate Injection, USP | Baxter Healthcare Corporation | Siegfried Hameln GmbH |
| 36000-300-01 | Dihydroergotamine Mesylate Injection, USP | Baxter Healthcare Corporation | Siegfried Hameln GmbH |
| 36000-300-10 | Dihydroergotamine Mesylate Injection, USP | Baxter Healthcare Corporation | Siegfried Hameln GmbH |
| 64896-509 | These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited |
| 64896-509-01 | These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited |
| 64896-509-02 | These highlights do not include all the information needed to use BREKIYA ® safely and effectively. See full prescribing information for BREKIYA ® . BREKIYA ® (dihydroergotamine mesylate) injection, for subcutaneous use Initial U.S. Approval: 1946 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited |
| 68083-466 | Dihydroergotamine Mesylate Injection, USP | Gland Pharma Limited |
| 68083-466-10 | Dihydroergotamine Mesylate Injection, USP | Gland Pharma Limited |
| 68682-357 | Dihydroergotamine Mesylate Nasal Spray | Oceanside Pharmaceuticals | MIPHARM SPA |
| 68682-357-10 | Dihydroergotamine Mesylate Nasal Spray | Oceanside Pharmaceuticals | MIPHARM SPA |
| 69097-503 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Cipla USA Inc. | Mipharm SpA |
| 69097-503-27 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Cipla USA Inc. | Mipharm SpA |
| 69097-503-31 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Cipla USA Inc. | Mipharm SpA |
| 70069-880 | DIHYDROERGOTAMINE MESYLATE Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only | Somerset Therapeutics, LLC | Mipharm S.p.A |
| 70069-880-01 | DIHYDROERGOTAMINE MESYLATE Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only | Somerset Therapeutics, LLC | Mipharm S.p.A |
| 70069-880-08 | DIHYDROERGOTAMINE MESYLATE Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. Rx Only | Somerset Therapeutics, LLC | Mipharm S.p.A |
| 70529-030 | Dromelate Injection System | IT3 Medical LLC |
| 70529-030-01 | Dromelate Injection System | IT3 Medical LLC |
| 71357-013 | Dihydroergotamine Mesylate Injection, USP Rx only | Milla Pharmaceuticals Inc. |
| 71357-013-01 | Dihydroergotamine Mesylate Injection, USP Rx only | Milla Pharmaceuticals Inc. |
| 71357-013-05 | Dihydroergotamine Mesylate Injection, USP Rx only | Milla Pharmaceuticals Inc. |
| 71357-013-10 | Dihydroergotamine Mesylate Injection, USP Rx only | Milla Pharmaceuticals Inc. |
| 72888-096 | Dihydroergotamine mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. | Advagen Pharma Ltd | Mipharm, S.p.A. |
| 72888-096-18 | Dihydroergotamine mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. | Advagen Pharma Ltd | Mipharm, S.p.A. |
| 72888-096-19 | Dihydroergotamine mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. | Advagen Pharma Ltd | Mipharm, S.p.A. |
| 72888-096-34 | Dihydroergotamine mesylate Nasal Spray The solution used in dihydroergotamine mesylate nasal spray (4 mg/mL) is intended for intranasal use and must not be injected. | Advagen Pharma Ltd | Mipharm, S.p.A. |
| 73352-096 | Dihydroergotamine Mesylate Nasal Spray | Trifluent Pharma, LLC |
| 73352-096-18 | Dihydroergotamine Mesylate Nasal Spray | Trifluent Pharma, LLC |
| 73352-096-19 | Dihydroergotamine Mesylate Nasal Spray | Trifluent Pharma, LLC |
| 76282-680 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Exelan Pharmaceuticals, Inc. | Mipharm S.p.A., Italy |
| 76282-680-43 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Exelan Pharmaceuticals, Inc. | Mipharm S.p.A., Italy |
| 76282-680-44 | Dihydroertotamine Mesylate Nasal Spray, 4 mg/mL | Exelan Pharmaceuticals, Inc. | Mipharm S.p.A., Italy |
| 76978-101 | These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946 | Satsuma Pharmaceuticals, Inc. |
| 76978-101-08 | These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946 | Satsuma Pharmaceuticals, Inc. |
| 76978-101-11 | These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946 | Satsuma Pharmaceuticals, Inc. |
| 77530-725 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA™ (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA ® (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-00 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA ® (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-00 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA™ (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-04 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA ® (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-04 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA™ (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-06 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA ® (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 77530-725-06 | These highlights do not include all the information needed to use TRUDHESA safely and effectively. See full prescribing information for TRUDHESA. TRUDHESA™ (dihydroergotamine mesylate) nasal spray Initial U.S. Approval: 1946 | Impel Pharmaceuticals LLC |
| 81284-411 | Dihydroergotamine Mesylate Injection, USP | Provepharm Inc. |
| 81284-411-00 | Dihydroergotamine Mesylate Injection, USP | Provepharm Inc. |
| 81284-411-05 | Dihydroergotamine Mesylate Injection, USP | Provepharm Inc. |
| 81284-411-10 | Dihydroergotamine Mesylate Injection, USP | Provepharm Inc. |